Efficacy and safety of pembrolizumab combined with albumin-bound paclitaxel and nedaplatin for advanced esophageal squamous cell carcinoma
Article in Immunotherapy (January 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Immunotherapy (January 2024)
Article in Medicine (October 2023)
Article in Medicine (August 2023)